Search research articles
Contact Us
Filters
Showing results (331-340 of 387) with videos related to
Page
of 39
Sort By:
Plos One
|
March 5, 2015
Innovative delivery of siRNA to solid tumors by super carbonate apatite
Xin Wu, Hirofumi Yamamoto, Hiroyuki Nakanishi, et al.
The Oncologist
|
February 28, 2013
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901
Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, et al.
The International Journal of Biological Markers
|
January 31, 2015
Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues
Sodai Narumi, Yasuhiro Miki, Shuko Hata, et al.
JTO Clinical and Research Reports
|
June 12, 2023
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study
Yoshihito Kogure, Akiko Kada, Hiroya Hashimoto, et al.
Allergology International : Official Journal of the Japanese Society of Allergology
|
April 3, 2022
Early introduction of very small amounts of multiple foods to infants: A randomized trial
Tatsuo Nishimura, Mitsuru Fukazawa, Keisuke Fukuoka, et al.
Cancer Chemotherapy and Pharmacology
|
April 14, 2018
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab
Satoru Nihei, Junya Sato, Toshiyuki Harada, et al.
Journal of Pain and Symptom Management
|
April 20, 2023
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study
Masanori Mori, Takashi Yamaguchi, Kozue Suzuki, et al.
Cancer Science
|
May 29, 2018
ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor-naïve Japanese patients with EGFR mutation-positive non-small-cell lung cancer
Koichi Azuma, Makoto Nishio, Hidetoshi Hayashi, et al.
The Oncologist
|
May 15, 2012
Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial
Satoshi Oizumi, Kunihiko Kobayashi, Akira Inoue, et al.
Journal of Palliative Medicine
|
September 16, 2025
Body Positioning for Dyspnea in Patients with Cancer with Unilateral Pleural Effusion: A Pilot Trial
Jun Kako, Yoshinobu Matsuda, Tomoo Ikari, et al.
Page
of 39
Search research articles
Search
Showing results (331-340 of 387) with videos related to
Sort By:
Page
of 39
Plos One
|
March 5, 2015
Innovative delivery of siRNA to solid tumors by super carbonate apatite
Xin Wu, Hirofumi Yamamoto, Hiroyuki Nakanishi, et al.
The Oncologist
|
February 28, 2013
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901
Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, et al.
The International Journal of Biological Markers
|
January 31, 2015
Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues
Sodai Narumi, Yasuhiro Miki, Shuko Hata, et al.
JTO Clinical and Research Reports
|
June 12, 2023
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study
Yoshihito Kogure, Akiko Kada, Hiroya Hashimoto, et al.
Allergology International : Official Journal of the Japanese Society of Allergology
|
April 3, 2022
Early introduction of very small amounts of multiple foods to infants: A randomized trial
Tatsuo Nishimura, Mitsuru Fukazawa, Keisuke Fukuoka, et al.
Cancer Chemotherapy and Pharmacology
|
April 14, 2018
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab
Satoru Nihei, Junya Sato, Toshiyuki Harada, et al.
Journal of Pain and Symptom Management
|
April 20, 2023
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study
Masanori Mori, Takashi Yamaguchi, Kozue Suzuki, et al.
Cancer Science
|
May 29, 2018
ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor-naïve Japanese patients with EGFR mutation-positive non-small-cell lung cancer
Koichi Azuma, Makoto Nishio, Hidetoshi Hayashi, et al.
The Oncologist
|
May 15, 2012
Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial
Satoshi Oizumi, Kunihiko Kobayashi, Akira Inoue, et al.
Journal of Palliative Medicine
|
September 16, 2025
Body Positioning for Dyspnea in Patients with Cancer with Unilateral Pleural Effusion: A Pilot Trial
Jun Kako, Yoshinobu Matsuda, Tomoo Ikari, et al.
Page
of 39